Type 1 autoimmune hepatitis in children and adolescents: Assessment of immunosuppressive treatment withdrawal

Jornal de Pediatria

Volumn 81, Issue 4, 2005, Pages 343-348

  Ferreira, Alexandre Rodrigues ^a,b   Roquete, Mariza Leitão Valadares ^a   Penna, Francisco José ^a   Toppa, Nivaldo H ^b   De Castro, Lúcia Porto Fonseca ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UFMG ^*

Author keywords

Adolescents; Autoimmune hepatitis; Children; Immunosuppressive treatment

Indexed keywords

ADOLESCENT; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; RECURRENCE RISK; RETROSPECTIVE STUDY; TREATMENT WITHDRAWAL; BIOPSY; EPIDEMIOLOGY; EVALUATION; INFANT; LIVER; PATHOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; REMISSION; TIME;

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER; MALE; RECURRENCE; REMISSION INDUCTION; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 28244441690     PISSN: 00217557     EISSN: 00217557     Source Type: Journal    
DOI: 10.2223/1371     Document Type: Article

References (30)

1. Maggiore G, Bernard O, Homberg JC, Hadchouel M, Alvarez F, Hadchouel M, et al. Liver disease associated with anti-liver-kidney microssome antibody in children. J. Pediatr. 1986;108:399-404.
2. Maggiore G, Veber F, Bernard O, Hadchouel M, Homberg JC, Alvarez F, et. al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr. 1993;17:376-81.
3. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998-1005.
4. Alvarez F, Berg PA, Bianchei FB, Bianchi L, Burroughs AK, Cançado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929-38.
5. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479-97.
6. Dubois RS, Silverman A. Treatment of chronic active hepatitis in children. Postgrad Med J. 1974;50:386-91.
7. Arasu TS, Wyllie R, Hatch TF. Management of chronic aggressive hepatitis in children and adolescents. J Pediatr. 1979;95:514-22.
8. Maggiore G, Bernard O, Hadchouel M, Hadchouel P, Odievre M, Alagille D. Treatment of autoimmune chronic active hepatitis in childhood. J Pediatr. 1984;104:839-44.
9. Vegnente A, Larcher VF, Mowat AP, Portmann B, Williams R. Duration of chronic active hepatitis and the development of cirrhosis. Arch Dis Child. 1984;59:330-5.
10. Codoñer-Franch P, Bernard O, Maggiore G, Alagille D, Alvarez F. Clinical and immunological heterogeneity of anti-liver-kidney microssome antibody-positive autoimmune hepatitis in children. J Pediat Gastroenterol Nutr. 1989;9:436-40.
11. Porta G. Hepatite auto-imune na infância: análise clínico-laboratorial, histológica e evolutiva. [tese]. São Paulo: Faculdade de Medicina, Universidade de São Paulo; 1993.
12. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 1997;25:541-7.
13. Hajoui O, Debray D, Martin S, Alvarez F. Auto-antibodies to the asialoglycoprotein receptor in sera of children with auto-immune hepatitis. Eur J Pediatr. 2000;159:310-3.
14. Lambiase L, Davis GL. Treatment of chronic hepatitis. Gastroenterol Clin North Am. 1992;21:659-77.
15. Hergarty JE, Nouri-Aria KT, Portman B, Eddleston AL, Williams R. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology. 1983;3:685-9.
16. Czaja AJ, Beaver SJ, Shiels MT. Sustained remission following corticosteroid therapy of severe HBsAg-negative chronic active hepatitis. Gastroenterology. 1987;92:215-19.
17. Kanzler S, Gerken G, Lohr H, Galle PR, Meyer zum Buschenfeld KH, Lohse AW, et al. Duration of immunosuppressive therapy in auto-immune hepatitis. J Hepatol. 2001;34:354-5.
18. Czaja AJ, Menon KV, Carpenter HA. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology. 2002;35:890-7.
19. Ferreira AR, Roquete ML, Penna FJ, Toppa NH. Hepatite autoimune em crianças e adolescentes: estudo clínico, diagnóstico e resposta terapêutica. J Pediatr (Rio J). 2002;78:309-14.
20. Ishak K, Baptista A, Bianchi L, Callea F, Groote JD, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-9.
21. Maggiore G, Bernard O, Hadchouel M, Hadchouel P, Odievre M, Alagille D. Treatment of autoimmune chronic active hepatitis in childhood. J Pediatr. 1984;104:839-44.
22. Czaja AJ, Ammon HV, Summerskill WH. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission. Gastroenterol. 1980;78: 518-23.
23. Czaja AJ, Ludwig J, Baggenstoss AH, Wolf A. Corticosteroid-treated chronic active hepatitis in remission. N Engl J Med. 1981;304:5-9.
24. Johnson PJ, McFarlane IG. Chronic active hepatitis. Gut. 1991;Suppl:S63-72.
25. Czaja AJ. Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis. Hepatology. 1990;11:1044-9.
26. Bittencourt PL, Golberg AC, Cançado EL, Porta G, Carrilho FJ, Parias AQ, et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am. J. Gastroenterol. 1999;94:1906-13.
27. Bittencourt PL, Golberg AC, Cançado EL, Porta G, Laudanna AA, Kalil J. HLA-Dr different HLA profiles confer susceptibility to autoimmune hepatitis type 1 and 2. Am J Gastroenterol. 1998;93:1394-5.
28. Bittencourt PL, Palacios SA, Cançado EL, Porta G, Drigo S, Carrilho FJ, et al. Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor a polymorphisms at position - 308. J Hepatol. 2001;35:24-8.
29. Czaja AJ, Souto EO, Bittencourt PL, Cançado EL, Porta G, Goldberg AC, et al. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol. 2002;37:302-8.
30. Pando M, Larriba J, Fernandez GC, Fainboim H, Ciocca M, Ramonet M, et al. Pediatric and adult forms of type 1 autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology. 1999;30:1374-80.